(Press-News.org) Contact information: Dr. Giles Story
g.story@ucl.ac.uk
44-783-480-2314
Public Library of Science
Dreading pain can be worse than pain itself
Press release from PLOS Computational Biology
Faced with inevitable pain, most people choose to "get it out of the way" as soon as possible, according to research published this week in PLOS Computational Biology. In the study, which was conducted from the Institute for Global Health Innovation, Imperial College London, and the Wellcome Trust Centre for Neuroimaging, University College London, participants chose between real painful stimuli in the form of electric shocks, and imagined painful dental appointments occurring at different times in the future. Whilst most people chose to hasten the experience of pain, and would even accept more severe pain to avoid having to wait for it, a smaller proportion preferred to "put it off" into the future.
The anticipation of pain is a major source of misery. People who suffer from long-standing painful conditions report that the dread of worsening future pain can be more disabling than the pain itself. The general phenomenon is typically referred to as 'negative time preference'. The research team, led by Dr Giles Story, sought to better understand the fundamental processes by which people anticipate pain, with the hope of providing new insight into these conditions.
The researchers propose that the dread of pain increases as the predicted time of pain approaches. They demonstrate that if people focus only on the approaching pain itself, they will choose to defer pain into the future if possible, to reduce their immediate dread. By contrast, if people also take into account the dread they may experience in waiting for a painful event, the prospective unpleasantness of a prolonged period of dread may even exceed the unpleasantness of the pain itself. The researchers show that, in such cases, the prospect of pain becomes more unpleasant the more the pain is delayed, and people will therefore choose to expedite unavoidable pain.
The authors conclude that, "Further research is required to uncover the constitutive mechanisms of dread". For clinicians and health policy makers, a greater understanding of these mechanisms could inform the way in which potentially painful investigations and treatments are practised.
###
Financial disclosure: This work was supported by the Wellcome Trust [Ray Dolan Senior Investigator Award 098362/Z/12/Z]. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Citation: Story GW, Vlaev I, Seymour B, Winston JS, Darzi A, et al. (2013) Dread and the Disvalue of Future Pain. PLoS Comput Biol 9(11): e1003335. doi:10.1371/journal.pcbi.1003335
Please add this link to the freely available article in online versions of your report (the link will go live when the embargo ends):
http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1003335
Contact:
Name: Dr. Giles Story
Institution: Imperial College London, University College London
Department: Institute of Neurology, Wellcome Trust Centre for Neuroimaging
Phone: +447834802314
Email: g.story@imperial.ac.uk;g.story@ucl.ac.uk
Disclaimer
This press release refers to an upcoming article in PLOS Computational Biology. The release is provided by the article authors. Any opinions expressed in these releases or articles are the personal views of the journal staff and/or article contributors, and do not necessarily represent the views or policies of PLOS. PLOS expressly disclaims any and all warranties and liability in connection with the information found in the releases and articles and your use of such information.
About PLOS Computational Biology
PLOS Computational Biology (http://www.ploscompbiol.org) features works of exceptional significance that further our understanding of living systems at all scales through the application of computational methods. All works published in PLOS Computational Biology are open access. Everything is immediately available subject only to the condition that the original authorship and source are properly attributed. Copyright is retained.
About the Public Library of Science
The Public Library of Science (PLOS) is a nonprofit publisher and advocacy organization founded to accelerate progress in science and medicine by leading a transformation in research communication. PLOS engages in outreach activities that promote Open Access and innovations in the communication of research for scientists and the public. 2013 marks PLOS's tenth year as an Open Access publisher, reaching an international audience through immediate and free availability of research on the Internet. PLOS publishes a suite of seven journals: PLOS Biology, PLOS Medicine, PLOS Genetics, PLOS Computational Biology, PLOS Pathogens, and PLOS Neglected Tropical Diseases and PLOS ONE, which publishes research from more than 50 diverse scientific fields and is the largest journal in the world.
Dreading pain can be worse than pain itself
Press release from PLOS Computational Biology
2013-11-22
ELSE PRESS RELEASES FROM THIS DATE:
UEA researchers pioneer first patient-specific 3-D virtual birth simulator
2013-11-22
UEA researchers pioneer first patient-specific 3-D virtual birth simulator
Computer scientists from the University of East Anglia are working to create a virtual birthing simulator that will help doctors and midwives prepare for unusual or dangerous births.
The ...
Lowering 3 risk factors could cut obesity-related risk of heart disease by more than half
2013-11-22
Lowering 3 risk factors could cut obesity-related risk of heart disease by more than half
Research looks at blood pressure, cholesterol, blood glucose
Boston, MA — Controlling blood pressure, serum cholesterol, and blood glucose may substantially reduce the ...
Lowering blood pressure, cholesterol and blood sugar could halve obesity-related risk of heart disease
2013-11-22
Lowering blood pressure, cholesterol and blood sugar could halve obesity-related risk of heart disease
Controlling blood pressure, cholesterol, and blood glucose may substantially reduce the risk of heart disease and stroke associated with being overweight ...
Astronomers reveal mystery of brightest ever gamma-ray burst
2013-11-22
Astronomers reveal mystery of brightest ever gamma-ray burst
New research explains celestial phenomenon recorded earlier this year
For the first time, a team of astronomers from around the world, including experts from the University of Leicester, have used ...
Research reveals details of how flu evolves to escape immunity
2013-11-22
Research reveals details of how flu evolves to escape immunity
Study shows that seasonal flu escapes immunity with single amino acid substitutions
Scientists have identified a potential way to improve future flu vaccines after discovering that seasonal flu ...
Cosmic finding ushers in 'new age of astronomy'
2013-11-22
Cosmic finding ushers in 'new age of astronomy'
UD researchers part of international team that identifies very high-energy neutrinos coming from outside our solar system
Neutrinos can zip right through your body, the walls of your house, entire planets, even ...
Rutgers-Camden nursing scholar develops tool for ostomy care
2013-11-22
Rutgers-Camden nursing scholar develops tool for ostomy care
CAMDEN — Nurses caring for ostomy patients will now be equipped with an essential new tool that provides them with the first comprehensive guide to optimize ostomy management and enhance patient safety. ...
Healthy lifestyle before conception may increase likelihood of a healthy pregnancy
2013-11-22
Healthy lifestyle before conception may increase likelihood of a healthy pregnancy
Leading a healthy lifestyle in the months prior to conception as well as during pregnancy could potentially decrease the chance of complications
Leading a healthy lifestyle ...
Black hole birth captured by cosmic voyeurs
2013-11-22
Black hole birth captured by cosmic voyeurs
Los Alamos scientists get ringside seats at rare event
LOS ALAMOS, N.M., Nov. 21, 2013—Intelligent telescopes designed by Los Alamos National Laboratory got a front row seat recently for an unusual birth.
"Los ...
SU2C researcher identifies potential treatment option for melanoma
2013-11-22
SU2C researcher identifies potential treatment option for melanoma
The Allan H. (Bud) and Sue Selig Stand Up To Cancer Melanoma Innovative Research grant yields insight into melanoma drug resistance pathways and identifies potential new treatment option
November ...
LAST 30 PRESS RELEASES:
Black youth, especially Black girls, use mental health services less than their White peers
Canada must protect youth from sports betting advertising
First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer
Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial
Higher blood pressure in childhood linked to earlier death from heart disease in adulthood
AI helped older adults report accurate blood pressure readings at home
High blood pressure in childhood and premature cardiovascular disease mortality
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high
[Press-News.org] Dreading pain can be worse than pain itselfPress release from PLOS Computational Biology